BIT
ANAC

BlackRock Institutional Trust’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

BlackRock Institutional Trust’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,072,344
Closed -$57.3M – 4078
2016
Q1 		$57.3M Buy
1,072,344
+5,142
+0.5% +$380K 0.01% 1139
2015
Q4 		$121M Buy
1,067,202
+20,190
+2% +$2.22M 0.02% 743
2015
Q3 		$123M Buy
1,047,012
+91,684
+10% +$12M 0.02% 731
2015
Q2 		$74M Sell
955,328
-74,118
-7% -$4.86M 0.01% 1081
2015
Q1 		$59.6M Buy
1,029,446
+432,630
+72% +$18.4M 0.01% 1220
2014
Q4 		$19.2M Buy
596,816
+202,162
+51% +$6.07M ﹤0.01% 1939
2014
Q3 		$9.66M Sell
394,654
-71,003
-15% -$1.44M ﹤0.01% 2369
2014
Q2 		$8.26M Buy
465,657
+166,568
+56% +$2.68M ﹤0.01% 2544
2014
Q1 		$5.99M Buy
299,089
+8,299
+3% +$161K ﹤0.01% 2713
2013
Q4 		$4.88M Sell
290,790
-14,646
-5% -$203K ﹤0.01% 2797
2013
Q3 		$3.24M Sell
305,436
-22,020
-7% -$193K ﹤0.01% 2915
2013
Q2 		$1.83M Buy
+327,456
New +$1.98M ﹤0.01% 3124

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

BlackRock Institutional Trust's ANAC Position: Q2 2016 in Review

BlackRock Institutional Trust sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,072,344 shares — an estimated $57.3M sold.

BlackRock Institutional Trust first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $123M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • BlackRock Institutional Trust reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 1,072,344 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $57.3M.
  • BlackRock Institutional Trust first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • BlackRock Institutional Trust's ANACOR PHARMACEUTICALS INC COM position peaked at $123M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on BlackRock Institutional Trust's 13F filing for Q2 2016, filed 10 Aug 2016.